OTCMKTS:MKKGY Merck KGaA Q2 2025 Earnings Report $31.64 -0.07 (-0.21%) As of 07/24/2026 03:59 PM Eastern ProfileEarnings HistoryForecast Merck KGaA EPS ResultsActual EPS$0.57Consensus EPS $0.51Beat/MissBeat by +$0.06One Year Ago EPSN/AMerck KGaA Revenue ResultsActual Revenue$6.11 billionExpected Revenue$5.34 billionBeat/MissBeat by +$765.90 millionYoY Revenue GrowthN/AMerck KGaA Announcement DetailsQuarterQ2 2025Date8/7/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsMerck KGaA's next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Merck KGaA Earnings HeadlinesMerck KGaA (MKKGY) Moves to Strong Buy: Rationale Behind the UpgradeJuly 23 at 6:25 PM | uk.finance.yahoo.comMerck KGaA (OTCMKTS:MKKGY) Given Average Recommendation of "Hold" by AnalystsJuly 16, 2026 | americanbankingnews.comThey’re still buying the wrong AI stocksTesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be. History shows a similar pattern: Cisco collapsed in 2000, but the internet went on to reshape the world. The lesson applies now as markets question massive AI infrastructure spending. The real opportunity may be Phase 2 AI stocks - companies using AI to dominate cybersecurity, logistics, pharma, and other essential industries. | The Oxford Club (Ad)Merck KGaA (MKKGY) Stock ForecastsJuly 3, 2026 | ca.finance.yahoo.comMerck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?June 26, 2026 | finance.yahoo.comGermany's Merck Is Buying Bio-Techne for $11.3 BillionJune 25, 2026 | barrons.comSee More Merck KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email. Email Address About Merck KGaAMerck KGaA (OTCMKTS:MKKGY), Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co.; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY. Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility. The Life Science division supplies reagents, lab consumables, filtration and chromatography solutions, and bioprocessing technologies to research institutions and biopharmaceutical manufacturers — operations that include the MilliporeSigma brand in the United States and Canada following the acquisition of Sigma‑Aldrich. The Electronics business produces high‑performance materials and specialty chemicals used in semiconductor fabrication, display technologies and other advanced industrial applications. The company operates globally, serving customers across Europe, the Americas, Asia and other regions through manufacturing sites, research centers and commercial affiliates. Since May 2021 Merck KGaA has been led by Chair of the Executive Board and CEO Belén Garijo. Merck emphasizes integrated R&D and partnerships to support pharmaceutical development, laboratory science and materials innovation, positioning itself as a diversified supplier to healthcare, research and high‑technology industries.View Merck KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 07/20- 07/24Telecom Earnings Reveal a Sector That Finally Looks HealthierAMD and Cerbras Create A New Blueprint For HardwareIntel Earnings Reveal Whether the Chip Selloff Created a BuyDefense Earnings Show Readiness Now and Modernization AheadFreeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good EnoughTesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Upcoming Earnings Baker Hughes (7/26/2026)Nucor (7/27/2026)Cadence Design Systems (7/27/2026)Coca Cola Femsa (7/27/2026)Welltower (7/27/2026)Astrazeneca (7/27/2026)PACCAR (7/28/2026)Ford Motor (7/28/2026)Boeing (7/28/2026)Ecolab (7/28/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
